Selected research
Industry Growth & Trends
Global Fish-Oil Based Drugs Industry Growth and Trends Forecast to 2032
Market perspective
The global Fish-Oil Based Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Fish-Oil Based Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Fish-Oil Based Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Fish-Oil Based Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Fish-Oil Based Drugs include Aker Biomarine, BASF SE, Cellana, Clover Corporation, Croda International PLC, GC Rieber Oil, Omega Protein Corporation, Pharma Marine and Solutex GC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Fish-Oil Based Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Fish-Oil Based Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Fish-Oil Based Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Fish-Oil Based Drugs.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Fish-Oil Based Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Fish-Oil Based Drugs Market by Company
Aker Biomarine
BASF SE
Cellana
Clover Corporation
Croda International PLC
GC Rieber Oil
Omega Protein Corporation
Pharma Marine
Solutex GC
Stepan Company
United Laboratories
Fish-Oil Based Drugs Segment by Type
Salmon
Mackerel
Tuna
Herring
Others
Fish-Oil Based Drugs Segment by Application
Stroke
Dysmenorrhea
Rheumatoid Arthritis
Raynaud's Syndrome
Coronary Heart Disease (CHD)
Other
Fish-Oil Based Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fish-Oil Based Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fish-Oil Based Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fish-Oil Based Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fish-Oil Based Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Fish-Oil Based Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Salmon
- Mackerel
- Tuna
- Herring
- Others
Applications
- Stroke
- Dysmenorrhea
- Rheumatoid Arthritis
- Raynaud's Syndrome
- Coronary Heart Disease (CHD)
- Other
Companies covered
- Aker Biomarine
- BASF SE
- Cellana
- Clover Corporation
- Croda International PLC
- GC Rieber Oil
- Omega Protein Corporation
- Pharma Marine
- Solutex GC
- Stepan Company
- United Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Fish-Oil Based Drugs Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Fish-Oil Based Drugs Sales Estimates and Forecasts (2021-2032)
- 1.3 Fish-Oil Based Drugs Market by Type
- 1.3.1 Salmon
- 1.3.2 Mackerel
- 1.3.3 Tuna
- 1.3.4 Herring
- 1.3.5 Others
- 1.4 Global Fish-Oil Based Drugs Market Size by Type
- 1.4.1 Global Fish-Oil Based Drugs Market Size Overview by Type (2021-2032)
- 1.4.2 Global Fish-Oil Based Drugs Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Fish-Oil Based Drugs Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Fish-Oil Based Drugs Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Fish-Oil Based Drugs Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Fish-Oil Based Drugs Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Fish-Oil Based Drugs Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Fish-Oil Based Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Fish-Oil Based Drugs Industry Trends
- 2.2 Fish-Oil Based Drugs Industry Drivers
- 2.3 Fish-Oil Based Drugs Industry Opportunities and Challenges
- 2.4 Fish-Oil Based Drugs Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Fish-Oil Based Drugs Revenue (2021-2026)
- 3.2 Global Top Players by Fish-Oil Based Drugs Sales (2021-2026)
- 3.3 Global Top Players by Fish-Oil Based Drugs Price (2021-2026)
- 3.4 Global Fish-Oil Based Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Fish-Oil Based Drugs Major Company Production Sites & Headquarters
- 3.6 Global Fish-Oil Based Drugs Company, Product Type & Application
- 3.7 Global Fish-Oil Based Drugs Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Fish-Oil Based Drugs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Fish-Oil Based Drugs Players Market Share by Revenue in 2025
- 3.8.3 2025 Fish-Oil Based Drugs Tier 1, Tier 2, and Tier 3
4 Fish-Oil Based Drugs Regional Status and Outlook
- 4.1 Global Fish-Oil Based Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Fish-Oil Based Drugs Historic Market Size by Region
- 4.2.1 Global Fish-Oil Based Drugs Sales in Volume by Region (2021-2026)
- 4.2.2 Global Fish-Oil Based Drugs Sales in Value by Region (2021-2026)
- 4.2.3 Global Fish-Oil Based Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Fish-Oil Based Drugs Forecasted Market Size by Region
- 4.3.1 Global Fish-Oil Based Drugs Sales in Volume by Region (2027-2032)
- 4.3.2 Global Fish-Oil Based Drugs Sales in Value by Region (2027-2032)
- 4.3.3 Global Fish-Oil Based Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Fish-Oil Based Drugs by Application
- 5.1 Fish-Oil Based Drugs Market by Application
- 5.1.1 Stroke
- 5.1.2 Dysmenorrhea
- 5.1.3 Rheumatoid Arthritis
- 5.1.4 Raynaud's Syndrome
- 5.1.5 Coronary Heart Disease (CHD)
- 5.1.6 Other
- 5.2 Global Fish-Oil Based Drugs Market Size by Application
- 5.2.1 Global Fish-Oil Based Drugs Market Size Overview by Application (2021-2032)
- 5.2.2 Global Fish-Oil Based Drugs Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Fish-Oil Based Drugs Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Fish-Oil Based Drugs Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Fish-Oil Based Drugs Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Fish-Oil Based Drugs Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Fish-Oil Based Drugs Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Fish-Oil Based Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Aker Biomarine
- 6.1.1 Aker Biomarine Company Information
- 6.1.2 Aker Biomarine Business Overview
- 6.1.3 Aker Biomarine Fish-Oil Based Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Aker Biomarine Fish-Oil Based Drugs Product Portfolio
- 6.1.5 Aker Biomarine Recent Developments
- 6.2 BASF SE
- 6.2.1 BASF SE Company Information
- 6.2.2 BASF SE Business Overview
- 6.2.3 BASF SE Fish-Oil Based Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 BASF SE Fish-Oil Based Drugs Product Portfolio
- 6.2.5 BASF SE Recent Developments
- 6.3 Cellana
- 6.3.1 Cellana Company Information
- 6.3.2 Cellana Business Overview
- 6.3.3 Cellana Fish-Oil Based Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Cellana Fish-Oil Based Drugs Product Portfolio
- 6.3.5 Cellana Recent Developments
- 6.4 Clover Corporation
- 6.4.1 Clover Corporation Company Information
- 6.4.2 Clover Corporation Business Overview
- 6.4.3 Clover Corporation Fish-Oil Based Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Clover Corporation Fish-Oil Based Drugs Product Portfolio
- 6.4.5 Clover Corporation Recent Developments
- 6.5 Croda International PLC
- 6.5.1 Croda International PLC Company Information
- 6.5.2 Croda International PLC Business Overview
- 6.5.3 Croda International PLC Fish-Oil Based Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Croda International PLC Fish-Oil Based Drugs Product Portfolio
- 6.5.5 Croda International PLC Recent Developments
- 6.6 GC Rieber Oil
- 6.6.1 GC Rieber Oil Company Information
- 6.6.2 GC Rieber Oil Business Overview
- 6.6.3 GC Rieber Oil Fish-Oil Based Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 GC Rieber Oil Fish-Oil Based Drugs Product Portfolio
- 6.6.5 GC Rieber Oil Recent Developments
- 6.7 Omega Protein Corporation
- 6.7.1 Omega Protein Corporation Company Information
- 6.7.2 Omega Protein Corporation Business Overview
- 6.7.3 Omega Protein Corporation Fish-Oil Based Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Omega Protein Corporation Fish-Oil Based Drugs Product Portfolio
- 6.7.5 Omega Protein Corporation Recent Developments
- 6.8 Pharma Marine
- 6.8.1 Pharma Marine Company Information
- 6.8.2 Pharma Marine Business Overview
- 6.8.3 Pharma Marine Fish-Oil Based Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Pharma Marine Fish-Oil Based Drugs Product Portfolio
- 6.8.5 Pharma Marine Recent Developments
- 6.9 Solutex GC
- 6.9.1 Solutex GC Company Information
- 6.9.2 Solutex GC Business Overview
- 6.9.3 Solutex GC Fish-Oil Based Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Solutex GC Fish-Oil Based Drugs Product Portfolio
- 6.9.5 Solutex GC Recent Developments
- 6.10 Stepan Company
- 6.10.1 Stepan Company Company Information
- 6.10.2 Stepan Company Business Overview
- 6.10.3 Stepan Company Fish-Oil Based Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Stepan Company Fish-Oil Based Drugs Product Portfolio
- 6.10.5 Stepan Company Recent Developments
- 6.11 United Laboratories
- 6.11.1 United Laboratories Company Information
- 6.11.2 United Laboratories Business Overview
- 6.11.3 United Laboratories Fish-Oil Based Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 United Laboratories Fish-Oil Based Drugs Product Portfolio
- 6.11.5 United Laboratories Recent Developments
7 North America by Country
- 7.1 North America Fish-Oil Based Drugs Sales by Country
- 7.1.1 North America Fish-Oil Based Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Fish-Oil Based Drugs Sales by Country (2021-2026)
- 7.1.3 North America Fish-Oil Based Drugs Sales Forecast by Country (2027-2032)
- 7.2 North America Fish-Oil Based Drugs Market Size by Country
- 7.2.1 North America Fish-Oil Based Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Fish-Oil Based Drugs Market Size by Country (2021-2026)
- 7.2.3 North America Fish-Oil Based Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Fish-Oil Based Drugs Sales by Country
- 8.1.1 Europe Fish-Oil Based Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Fish-Oil Based Drugs Sales by Country (2021-2026)
- 8.1.3 Europe Fish-Oil Based Drugs Sales Forecast by Country (2027-2032)
- 8.2 Europe Fish-Oil Based Drugs Market Size by Country
- 8.2.1 Europe Fish-Oil Based Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Fish-Oil Based Drugs Market Size by Country (2021-2026)
- 8.2.3 Europe Fish-Oil Based Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Fish-Oil Based Drugs Sales by Country
- 9.1.1 Asia-Pacific Fish-Oil Based Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Fish-Oil Based Drugs Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Fish-Oil Based Drugs Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Fish-Oil Based Drugs Market Size by Country
- 9.2.1 Asia-Pacific Fish-Oil Based Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Fish-Oil Based Drugs Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Fish-Oil Based Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Fish-Oil Based Drugs Sales by Country
- 10.1.1 South America Fish-Oil Based Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Fish-Oil Based Drugs Sales by Country (2021-2026)
- 10.1.3 South America Fish-Oil Based Drugs Sales Forecast by Country (2027-2032)
- 10.2 South America Fish-Oil Based Drugs Market Size by Country
- 10.2.1 South America Fish-Oil Based Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Fish-Oil Based Drugs Market Size by Country (2021-2026)
- 10.2.3 South America Fish-Oil Based Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Fish-Oil Based Drugs Sales by Country
- 11.1.1 Middle East and Africa Fish-Oil Based Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Fish-Oil Based Drugs Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Fish-Oil Based Drugs Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Fish-Oil Based Drugs Market Size by Country
- 11.2.1 Middle East and Africa Fish-Oil Based Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Fish-Oil Based Drugs Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Fish-Oil Based Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Fish-Oil Based Drugs Value Chain Analysis
- 12.1.1 Fish-Oil Based Drugs Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Fish-Oil Based Drugs Production Mode & Process
- 12.2 Fish-Oil Based Drugs Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Fish-Oil Based Drugs Distributors
- 12.2.3 Fish-Oil Based Drugs Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst